EUG-92453-86169 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-26
Dose 1 — Pfizer-BioNTech
2021-04-19
Registered in v-safe
2021-04-19
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-04-20
Dose 2 — Pfizer-BioNTech
2021-04-21
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain

Adult check-in
2021-04-22
Survey response — days 1–6 daily, dose 2
MedDRA: Eye pain — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain

Free text: Eye pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-25
Survey response — days 1–6 daily, dose 2
MedDRA: Pregnancy — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea

Free text: These could be from pregnancy 29 weeks

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-27
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-05-04
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-26	Pfizer-BioNTech
2	2021-04-20	Pfizer-BioNTech

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-22

Systemic reaction (other): Eye pain

2021-04-25

Systemic reaction (other): These could be from pregnancy 29 weeks

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Eye pain	✓	✓	✓
SRO	Pregnancy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release